Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Standardized methods are needed to understand how process conditions affect extracellular vesicle protein content for skin therapy.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Selenium from plants is beneficial and safer for health.

Vitex negundo has potential health benefits, including anti-inflammatory and anti-cancer effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.